Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials

Volume: 25, Issue: 1, Pages: 81 - 104
Published: Jan 1, 2003
Abstract
Pain is one of the most common reasons for seeking medical attention, and neuropathic pain is among the most common types of pain. Despite its prevalence, neuropathic pain is often underrecognized and inadequately treated. Many cases are refractory to the medications traditionally used for pain, such as nonsteroidal anti-inflammatory drugs. Tricyclic antidepressants are considered first-line agents for neuropathic pain, but their use is limited...
Paper Details
Title
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
Published Date
Jan 1, 2003
Volume
25
Issue
1
Pages
81 - 104
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.